ConductScience.org, home

Paper28545784

Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.

Leonard CE and 5 others. Trends Endocrinol Metab, 2017. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence. Papers, record 28545784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28545784

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.
PubMed
Journal
Trends Endocrinol Metab
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.32
iCite
Revised in PubMed
2024-06-03
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Leonard CECharles E
2Hennessy SSean
3Han XXu
4Siscovick DSDavid S
5Flory JHJames H
6Deo RRajat

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arrhythmias, CardiacMajor topic
Heart RateMajor topic
Hypoglycemic AgentsMajor topic
Sulfonylurea CompoundsMajor topic
Animals
Death, Sudden, Cardiac
Diabetes Mellitus, Type 2
Humans
Incidence
Ischemic Preconditioning, Myocardial

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K08 HS023898AHRQ HHSUnited StatesK08HS023898PubMed and NIHNIH RePORTER
R01 AG025152NIA NIH HHSUnited StatesR01AG025152PubMed and NIHNIH RePORTER
R01 DK102694NIDDK NIH HHSUnited StatesR01DK102694PubMed and NIHNIH RePORTER

Download CSV of grants

References181

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18595627KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.Cardiovasc Res1995https://conductscience.org/library/papers/8595627PubMed
21819892Effects of glibenclamide and tolbutamide on ischemia- and ouabain-induced arrhythmias and membrane potentials of ventricular myocardium from rat and guinea pig.Zhongguo Yao Li Xue Bao1991https://conductscience.org/library/papers/1819892PubMed
310409190Delayed preconditioning with adenosine is mediated by opening of ATP-sensitive K(+) channels in rabbit heart.Am J Physiol1999https://conductscience.org/library/papers/10409190PubMed
47713283QT prolongation in type 2 diabetes mellitus treated with glibenclamide.Diabete Metab1994https://conductscience.org/library/papers/7713283PubMed
512121705Oral hypoglycemic sulfonylurea glimepiride preserves the myoprotective effects of ischemic preconditioning.J Surg Res2002https://conductscience.org/library/papers/12121705PubMed
616966594Sudden cardiac death: better understanding of risks, mechanisms, and treatment.Circulation2006https://conductscience.org/library/papers/16966594PubMed
79024742Blockade of K(ATP) channels with glibenclamide does not abolish preconditioning during demand ischemia.Am J Cardiol1997https://conductscience.org/library/papers/9024742PubMed
810539800Relation between sulfonylurea therapy, complications, and outcome for elderly patients with acute myocardial infarction.Am Heart J1999https://conductscience.org/library/papers/10539800PubMed
99476676Nicorandil reduces myocardial infarct size by opening the K(ATP) channel in rabbits.Int J Cardiol1997https://conductscience.org/library/papers/9476676PubMed
1010821820Selective pharmacological agents implicate mitochondrial but not sarcolemmal K(ATP) channels in ischemic cardioprotection.Circulation2000https://conductscience.org/library/papers/10821820PubMed
1124910232Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes.Lancet2014https://conductscience.org/library/papers/24910232PubMed
1211004427Tissue-specific effects of sulfonylureas: lessons from studies of cloned K(ATP) channels.J Diabetes Complications2000https://conductscience.org/library/papers/11004427PubMed
1316444778Effects of sulfonylureas on mitochondrial ATP-sensitive K+ channels in cardiac myocytes: implications for sulfonylurea controversy.Diabetes Metab Res Rev2006https://conductscience.org/library/papers/16444778PubMed
148263798Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?J Pharmacol Exp Ther1993https://conductscience.org/library/papers/8263798PubMed
1520544609Diabetes mellitus and sudden cardiac death: what are the data?Cardiol J2010https://conductscience.org/library/papers/20544609PubMed
167475053Pharmacological analysis in rat of the role of the ATP-sensitive potassium channel as a potential target for antifibrillatory intervention in acute myocardial ischaemia.J Cardiovasc Pharmacol1995https://conductscience.org/library/papers/7475053PubMed
1711425777Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide.Circulation2001https://conductscience.org/library/papers/11425777PubMed
182119912Potassium accumulation in the globally ischemic mammalian heart. A role for the ATP-sensitive potassium channel.Circ Res1990https://conductscience.org/library/papers/2119912PubMed
1910988237Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals.Circ Res2000https://conductscience.org/library/papers/10988237PubMed
207477447Effects of cromakalim or glibenclamide on arrhythmias and dispersion of refractoriness in chronically infarcted in anesthetized dogs.Naunyn Schmiedebergs Arch Pharmacol1995https://conductscience.org/library/papers/7477447PubMed

See all 181 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
41481542Cardiac remodelling in type 2 diabetes: Pathophysiological mechanisms and opportunities for multiscale computational modelling and simulation.J Physiol2026https://conductscience.org/library/papers/41481542PubMed
41357784Exploring the Therapeutic Potential of Antidiabetic Drugs in Cardiac Arrhythmia Management: A Drug Target Mendelian Randomization Study.J Arrhythm2025https://conductscience.org/library/papers/41357784PubMed
41302503Potential Molecular Biomarkers for Predicting and Monitoring Complications in Type 2 Diabetes Mellitus.Molecules2025https://conductscience.org/library/papers/41302503PubMed
39433419
Do relationships between ambient temperature and serious adverse health outcomes vary among users of different antidiabetes drugs? A retrospective cohort study of US Medicaid beneficiaries with type 2 diabetes.
BMJ Open2024https://conductscience.org/library/papers/39433419PubMed
39336583Cardiovascular Effectiveness and Safety of Antidiabetic Drugs in Patients with Type 2 Diabetes and Peripheral Artery Disease: Systematic Review.Medicina (Kaunas)2024https://conductscience.org/library/papers/39336583PubMed
38856903Non-radioactive Rb+ Efflux Assay for Screening KATP Channel Modulators.Methods Mol Biol2024https://conductscience.org/library/papers/38856903PubMed
37646176Hypoxia Promotes Atrial Tachyarrhythmias via Opening of ATP-Sensitive Potassium Channels.Circ Arrhythm Electrophysiol2023https://conductscience.org/library/papers/37646176PubMed
36102222Sulfonylurea Is Associated With Higher Risks of Ventricular Arrhythmia or Sudden Cardiac Death Compared With Metformin: A Population-Based Cohort Study.J Am Heart Assoc2022https://conductscience.org/library/papers/36102222PubMed
36033393The Effects of 6 Common Antidiabetic Drugs on Anti-PD1 Immune Checkpoint Inhibitor in Tumor Treatment.J Immunol Res2022https://conductscience.org/library/papers/36033393PubMed
35207759Clinical Observation of SGLT2 Inhibitor Therapy for Cardiac Arrhythmia and Related Cardiovascular Disease in Diabetic Patients with Controlled Hypertension.J Pers Med2022https://conductscience.org/library/papers/35207759PubMed
35112189Metformin versus sulphonylureas for new onset atrial fibrillation and stroke in type 2 diabetes mellitus: a population-based study.Acta Diabetol2022https://conductscience.org/library/papers/35112189PubMed
34804796Unusual T-wave changes and extreme QTc prolongation in a 71-year-old man with asymptomatic COVID infection.HeartRhythm Case Rep2022https://conductscience.org/library/papers/34804796PubMed
34198942Characteristics of Ventricular Electrophysiological Substrates in Metabolic Mice Treated with Empagliflozin.Int J Mol Sci2021https://conductscience.org/library/papers/34198942PubMed
33896015Sulfonylurea antidiabetics are associated with lower risk of out-of-hospital cardiac arrest: Real-world data from a population-based study.Br J Clin Pharmacol2021https://conductscience.org/library/papers/33896015PubMed
32784369Effects of Secretome from Fat Tissues on Ion Currents of Cardiomyocyte Modulated by Sodium-Glucose Transporter 2 Inhibitor.Molecules2020https://conductscience.org/library/papers/32784369PubMed
32572080Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: An experience with conceptual replication in two independent populations.Sci Rep2020https://conductscience.org/library/papers/32572080PubMed
32098624The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety.Cardiovasc Diabetol2020https://conductscience.org/library/papers/32098624PubMed
31208937Methylome-wide association study provides evidence of particulate matter air pollution-associated DNA methylation.Environ Int2019https://conductscience.org/library/papers/31208937PubMed
30596400Functional protection against cardiac diseases depends on ATP-sensitive potassium channels.J Cell Mol Med2018https://conductscience.org/library/papers/30596400PubMed
30564287Evaluating the Diabetes-Cardiology interface: a glimpse into the diabetes management of cardiology inpatients in western Sydney's 'diabetes hotspot' and the establishment of a novel model of care.Diabetol Metab Syndr2018https://conductscience.org/library/papers/30564287PubMed

See all 22 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCC86833PubTator's text mininghttps://conductscience.org/library/genes/6833NCBI Gene
CMPK151727PubTator's text mininghttps://conductscience.org/library/genes/51727NCBI Gene
ERG2078PubTator's text mininghttps://conductscience.org/library/genes/2078NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28545784

GET https://conductscience.org/api/papers/v1/28545784/references?page=2